Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in KZIA — Kazia Therapeutics Ltd

CIK 1446194 BALA CYNWYD, PA
Back to KZIA Full portfolio

Position in KZIA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$712,673
+$712,673 QoQ
Shares Held
50,616
Ownership
0.443%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 35 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KZIA Over Time

Shares Held

Position Value (USD)

Derivatives in KZIA

reported options exposure · as of Jun 30, 2026
CallValue
$3,543,936
CallShares
251,700
PutValue
$430,848
PutShares
30,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. KZIA ranks #141 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in KZIA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $712,673 50,616
2026-06-30 $430,848 30,600
2026-06-30 $3,543,936 251,700
2024-12-31 $23,718 13,400
2024-09-30 $6,192 14,400
2024-06-30 $9,539 41,478
2022-03-31 $193,135 25,050
2021-12-31 $427,415 50,762
2021-09-30 $277,283 24,495
2021-06-30 $140,998 14,300
2021-06-30 $366,792 37,200
2021-06-30 $238,612 24,200
2021-03-31 $419,120 33,800
2021-03-31 $704,320 56,800
2021-03-31 $301,444 24,310
2020-12-31 $218,592 25,300